{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:39:14Z","timestamp":1791999554698,"version":"4.4.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This review compared the effectiveness of intrathecal dexmedetomidine with fentanyl as additives to hyperbaric bupivacaine for providing postoperative analgesia after Cesarean section.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>There are limited treatment options for pain following Cesarean section due to potential parturient and neonatal side effects. Intrathecal dexmedetomidine has emerged as an alternative to intrathecal opioids for prolonging postoperative analgesia, but its effectiveness requires further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria:<\/jats:title>\n                    <jats:p>The review evaluated studies of patients who underwent Cesarean section under spinal anesthesia where dexmedetomidine and fentanyl were compared as intrathecal additives to hyperbaric bupivacaine. The outcomes were postoperative pain scores in the first 24 hours, duration of analgesia, duration of motor block, and the incidence of side effects. Randomized controlled trials, non-randomized controlled trials, and prospective cohort studies were considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, Cochrane Central Register of Controlled Trials, Scopus, and Embase were searched in September 2023 and May 2024. ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and Google Scholar were searched for gray literature. Study selection, critical appraisal, data extraction, and data synthesis were conducted using the JBI methodology for systematic reviews of effectiveness. Assessment of the certainty in findings was conducted using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifteen studies (13 RCTs and 2 non-randomized, prospective cohort studies) with 1098 participants were included. The overall risk of bias was moderate. There was low to moderate certainty that dexmedetomidine results in lower pain scores up to 6 hours postoperatively, with only the difference at 4 hours greater than the minimum clinical important difference of 1 point on a numeric pain rating scale (2 RCTs, 100 participants; mean difference [MD] 1.26 points lower, 95% CI 1.78 to 0.74). There was low certainty that dexmedetomidine prolongs the duration of analgesia (8 RCTs, 578 participants; MD 93.3 minutes, 95% CI 62.40 to 124.19). There was very low certainty that dexmedetomidine prolongs the duration of motor block (8 RCTs, 502 participants; MD 29.68 minutes, 95% CI 0.96 to 58.40). There was low certainty that dexmedetomidine increases the risk of hypotension (10 RCTs, 688 participants; absolute difference of 2% increase in risk, 95% CI 6% decrease to 11% increase) and bradycardia (8 RCTs, 558 participants; absolute difference of 2% increase in risk, 95% CI 2% decrease to 8% increase). There was moderate certainty that dexmedetomidine decreases the risk of nausea and vomiting (8 RCTs, 558 participants; absolute difference of 7% decrease in risk, 95% CI 11% to 0% decrease); pruritus (7 RCTs, 442 participants; absolute difference of 11% decrease in risk, 95% CI 11% to 9% decrease); and shivering (5 RCTs, 390 participants; absolute difference of 8% decrease in risk, 95% CI 9% decrease to 3% decrease).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Dexmedetomidine probably results in a meaningfully lower pain score, limited to the fourth hour postoperatively, and may result in a longer duration of analgesia. Dexmedetomidine probably results in lower incidence of nausea and vomiting, pruritus, and shivering. Dexmedetomidine may increase the incidence of hypotension and bradycardia. It is uncertain whether dexmedetomidine results in a longer duration of motor block.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-24-00418","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:00:09Z","timestamp":1762250409000},"page":"2379-2418","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of intrathecal dexmedetomidine versus fentanyl as additives to hyperbaric bupivacaine on postoperative analgesia in patients undergoing Cesarean section: a systematic review and meta-analysis"],"prefix":"10.11124","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2171-9167","authenticated-orcid":false,"given":"Jorica","family":"Boshoff","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Faculty of Health Sciences, The University of Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-018X","authenticated-orcid":false,"given":"Maria","family":"Fourtounas","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Faculty of Health Sciences, The University of Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-3030","authenticated-orcid":false,"given":"Kylesh","family":"Pegu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Faculty of Health Sciences, The University of Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-8032","authenticated-orcid":false,"given":"Patricia","family":"McInerney","sequence":"additional","affiliation":[{"name":"JBI Center for Evidence-Based Practice University of the Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"6","key":"R1-20260406","doi-asserted-by":"crossref","first-page":"e005671","DOI":"10.1136\/bmjgh-2021-005671","article-title":"Trends and projections of Cesarean section rates: global and regional estimates","volume":"6","author":"Betran","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"1","key":"R3-20260406","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42077-020-00121-7","article-title":"Anesthesia for Cesarean delivery: general or regional anesthesia\u2014a systematic review","volume":"13","author":"Iddrisu","year":"2021","journal-title":"Ain-Shams J Anesthesiol"},{"issue":"12","key":"R4-20260406","first-page":"e3715","article-title":"The effect of spinal versus general anesthesia on quality of life in women undergoing Cesarean delivery on maternal request","volume":"10","author":"Ghaffari","year":"2018","journal-title":"Cureus"},{"issue":"4","key":"R5-20260406","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1213\/01.ane.0000167774.36833.99","article-title":"Patient preferences for anesthesia outcomes associated with Cesarean delivery","volume":"101","author":"Carvalho","year":"2005","journal-title":"Anesth Analg"},{"issue":"1","key":"R6-20260406","doi-asserted-by":"crossref","first-page":"69-79","DOI":"10.1016\/j.bpa.2017.01.003","article-title":"Postcesarean delivery analgesia","volume":"31","author":"Carvalho","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"R7-20260406","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/safp.v63i1.5320","article-title":"A retrospective audit of pain assessment and management postcesarean section at New Somerset Hospital in Cape Town, South Africa","volume":"63","author":"Munsaka","year":"2021","journal-title":"S Afr Fam Pract"},{"issue":"9","key":"R8-20260406","doi-asserted-by":"crossref","first-page":"265-70","DOI":"10.1016\/j.bjae.2018.05.006","article-title":"Pain management in low- and middle-income countries","volume":"18","author":"Morriss","year":"2018","journal-title":"BJA Educ"},{"issue":"4","key":"R9-20260406","doi-asserted-by":"crossref","first-page":"217-21","DOI":"10.1258\/td.2009.070497","article-title":"Postoperative analgesia following Cesarean deliveries in a rural health district of South Africa","volume":"39","author":"Khan","year":"2009","journal-title":"Trop Doct"},{"issue":"1","key":"R10-20260406","article-title":"The WHO Pain Ladder: do we need another step?","volume":"14","author":"Pergolizzi","year":"2014","journal-title":"Pract Pain Manag"},{"issue":"3","key":"R11-20260406","doi-asserted-by":"crossref","first-page":"247.e1-e9","DOI":"10.1016\/j.ajog.2019.04.012","article-title":"Guidelines for postoperative care in Cesarean delivery: Enhanced Recovery After Surgery (ERAS) Society recommendations (part 3)","volume":"221","author":"Macones","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"R12-20260406","doi-asserted-by":"crossref","first-page":"517-24","DOI":"10.1111\/j.1365-2044.1997.154-az0160.x","article-title":"Neonatal welfare and placental transfer of fentanyl and bupivacaine during ambulatory combined spinal epidural analgesia for labour","volume":"52","author":"Fernando","year":"1997","journal-title":"Anesthesia"},{"issue":"1","key":"R14-20260406","doi-asserted-by":"crossref","first-page":"111-25","DOI":"10.1213\/ANE.0000000000003975","article-title":"Efficacy of intrathecal fentanyl for Cesarean delivery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"130","author":"Uppal","year":"2020","journal-title":"Anesth Analg"},{"issue":"6","key":"R15-20260406","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/00000542-199912000-00045","article-title":"Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing Cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials","volume":"91","author":"Dahl","year":"1999","journal-title":"Anesthesiology"},{"issue":"1","key":"R16-20260406","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2249-4472.114253","article-title":"Dexmedetomidine in pregnancy: review of literature and possible use","volume":"3","author":"Nair","year":"2013","journal-title":"J Obstet Anaesth Crit Care"},{"issue":"5","key":"R17-20260406","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0300060520913423","article-title":"Dexmedetomidine as an adjuvant for single spinal anesthesia in patients undergoing Cesarean section: a system review and meta-analysis","volume":"48","author":"Shen","year":"2020","journal-title":"J Int Med Res"},{"key":"R18-20260406","doi-asserted-by":"crossref","first-page":"2933-9","DOI":"10.2147\/DDDT.S207812","article-title":"Effect of intrathecal dexmedetomidine on Cesarean section during spinal anesthesia: a meta-analysis of randomized trials","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"R19-20260406","doi-asserted-by":"crossref","first-page":"1613-25","DOI":"10.1177\/0300060517707113","article-title":"Fetal responses to dexmedetomidine in parturients undergoing Cesarean section: a systematic review and meta-analysis","volume":"45","author":"Zhang","year":"2017","journal-title":"J Int Med Res"},{"key":"R20-20260406","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fphar.2020.00342","article-title":"Effect of different doses of intrathecal dexmedetomidine as an adjuvant combined with hyperbaric ropivacaine in patients undergoing Cesarean section","volume":"11","author":"Bi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"R21-20260406","doi-asserted-by":"crossref","first-page":"268-73","DOI":"10.1007\/s00540-023-03163-x","article-title":"Respiratory depression following Cesarean section with single-shot spinal with 100 \u03bcg morphine","volume":"37","author":"Onodera","year":"2023","journal-title":"J Anesth"},{"issue":"5","key":"R23-20260406","first-page":"933-9","article-title":"Effectiveness of intrathecal dexmedetomidine vs fentanyl as additives to hyperbaric bupivacaine for postoperative analgesia in women undergoing Cesarean section: a systematic review protocol","volume":"22","author":"Boshoff","year":"2024","journal-title":"JBI Evid Synth"},{"issue":"1","key":"R24-20260406","doi-asserted-by":"crossref","first-page":"36-43","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"issue":"3","key":"R25-20260406","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"7650","key":"R26-20260406","doi-asserted-by":"crossref","first-page":"924-6","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R27-20260406","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1681803","article-title":"The anesthetic effect and safety of dexmedetomidine in Cesarean section: a meta-analysis","author":"Pang","year":"2022","journal-title":"BioMed Res Int"},{"issue":"1","key":"R29-20260406","first-page":"1083-7","article-title":"Intrathecal fentanyl versus dexmedetomidine as adjuvants to bupivacaine for Cesarean section","volume":"3","author":"El-Din","year":"2021","journal-title":"Int J Med Arts"},{"issue":"1","key":"R30-20260406","first-page":"6-10","article-title":"Motor and sensory blocking effect of intrathecal fentanyl versus dexmedetomidine as adjuvants to bupivacaine for Cesarean section","volume":"2","author":"El-Din","year":"2018","journal-title":"Sci J Al-Azhar Med Fac Girls"},{"issue":"2","key":"R31-20260406","first-page":"4060","article-title":"Comparative study of adding fentanyl or dexmedetomidine or morphine as adjuvant for intrathecal bupivacaine for Cesarean sections","volume":"9","author":"Rajkumar","year":"2022","journal-title":"Eur J Mol Clin Med"},{"issue":"2","key":"R32-20260406","first-page":"405","article-title":"Effectiveness of dexmedetomidine and fentanyl with intrathecal levobupivacaine in lower segment C-Section","volume":"15","author":"Iqbal","year":"2021","journal-title":"Pak J Med Health Sci"},{"issue":"8","key":"R33-20260406","doi-asserted-by":"crossref","first-page":"2537-41","DOI":"10.53350\/pjmhs211582537","article-title":"Comparison of dexmedetomidine and fentanyl as adjuvants to intrathecal levobupivacaine in lower segment Cesarean section","volume":"15","author":"Zafar","year":"2021","journal-title":"Pak J Med Health Sci"},{"issue":"1","key":"R34-20260406","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12871-020-01109-4","article-title":"The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing Cesarean section: a double-blind randomized controlled trial","volume":"20","author":"Li","year":"2020","journal-title":"BMC Anesthesiol"},{"key":"R35-20260406","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"R36-20260406","article-title":"A randomised controlled trial to evaluate the effectiveness of intrathecal bupivacaine combined with different adjuvants (fentanyl, clonidine and dexmedetomidine) in Cesarean section","volume":"65","author":"Li","year":"2015","journal-title":"Drug Res"},{"issue":"9","key":"R37-20260406","first-page":"468","article-title":"Comparative evaluation of intrathecal bupivacaine alone, bupivacaine-fentanyl, and bupivacaine-dexmedetomidine in Cesarean section","volume":"65","author":"Sun","year":"2015","journal-title":"Drug Res"},{"key":"R38-20260406","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/JPR.S265161","article-title":"Comparative study of fentanyl vs dexmedetomidine as adjuvants to intrathecal bupivacaine in Cesarean section: a randomized, double-blind clinical trial","volume":"13","author":"Khosravi","year":"2020","journal-title":"J Pain Res"},{"issue":"5","key":"R39-20260406","doi-asserted-by":"crossref","first-page":"616","DOI":"10.35975\/apic.v26i5.2019","article-title":"Intrathecal bupivacaine-fentanyl vs. bupivacaine-dexmedetomidine for Cesarean section: a randomized controlled trial","volume":"26","author":"Urooj","year":"2022","journal-title":"Anaesth Pain Intensive Care"},{"issue":"1","key":"R40-20260406","first-page":"221","article-title":"Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics and neonatal outcome in uncomplicated Cesarean delivery: a randomized double blind placebo controlled study","volume":"24","author":"Mahdy","year":"2011","journal-title":"Menoufiya Med J"},{"issue":"2","key":"R41-20260406","first-page":"218-26","article-title":"Comparing intrathecal dexmedetomidine and fentanyl as adjuvants to hyperbaric bupivacaine in elective Cesarean section","volume":"29","author":"Farooq","year":"2022","journal-title":"Prof Med J"},{"issue":"2","key":"R42-20260406","first-page":"112-5","article-title":"Comparison of antiemetic efficacy of intrathecal fentanyl and dexmedetomidine for Cesarean section in subarachnoid block","volume":"12","author":"Hasan","year":"2019","journal-title":"MedPulse Int J Anesthesiol"},{"issue":"65","key":"R43-20260406","first-page":"4206-10","article-title":"A comparative study of perioperative effects of intrathecal fentanyl and dexmedetomidine with bupivacaine in elective LSCS","volume":"6","author":"Mishra","year":"2017","journal-title":"J Evol Med Dent Sci"},{"issue":"4","key":"R45-20260406","first-page":"73-7","article-title":"Efficacy of intrathecal dexmedetomidine with bupivacaine versus fentanyl with bupivacaine in spinal anesthesia for elective Cesarean section","volume":"1","author":"Rao","year":"2019","journal-title":"EAS J Anesthesiol Crit Care"},{"issue":"1","key":"R46-20260406","doi-asserted-by":"crossref","first-page":"201-5","DOI":"10.33545\/26643766.2021.v4.i1c.268","article-title":"Comparative effects of dexmedetomidine and fentanyl as adjuvants to hyperbaric bupivacaine in elective Cesarean sections: an observational study at tertiary care centre","volume":"4","author":"Sheikh","year":"2021","journal-title":"Int J Med Anesthesiol"},{"issue":"1","key":"R47-20260406","doi-asserted-by":"crossref","first-page":"209","DOI":"10.58675\/2682-339X.1639","article-title":"Comparative study of dexmedetomidine versus fentanyl as adjuvant to bupivacaine spinal anesthesia in Cesarean section","volume":"4","author":"Mohammed","year":"2023","journal-title":"Al-Azhar Int Med J"},{"issue":"5","key":"R48-20260406","doi-asserted-by":"crossref","first-page":"665-80","DOI":"10.1111\/anae.15339","article-title":"PROSPECT guideline for elective Cesarean section: updated systematic review and procedure-specific postoperative pain management recommendations","volume":"76","author":"Roofthooft","year":"2021","journal-title":"Anesthesia"},{"issue":"1","key":"R49-20260406","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijoa.2019.08.004","article-title":"Evaluation of the impact of enhanced recovery after surgery protocol implementation on maternal outcomes following elective Cesarean delivery","volume":"43","author":"Kleinman","year":"2020","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"R50-20260406","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijoa.2020.01.005","article-title":"Impact of an enhanced recovery program for Cesarean delivery on postoperative opioid use","volume":"43","author":"Lester","year":"2020","journal-title":"Int J Obstet Anesth"},{"issue":"5","key":"R51-20260406","doi-asserted-by":"crossref","first-page":"445-54","DOI":"10.23736\/S0375-9393.22.16969-5","article-title":"\u03b1-2 agonists vs. fentanyl as adjuvants for spinal anesthesia in elective Cesarean section: a meta-analysis","volume":"89","author":"La Via","year":"2023","journal-title":"Minerva Anestesiol"},{"issue":"5","key":"R52-20260406","first-page":"e13772","article-title":"Dexmedetomidine versus fentanyl as adjuvants to ropivacaine for epidural anesthesia: a systematic review and meta-analysis","volume":"75","author":"Qian","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"1","key":"R54-20260406","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12913-019-3911-x","article-title":"Postoperative pain after Cesarean section: assessment and management in a tertiary hospital in a low-income country","volume":"19","author":"Kintu","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"R55-20260406","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijoa.2020.05.006","article-title":"Enhanced Recovery After Cesarean (ERAC) \u2013 beyond the pain scores","volume":"43","author":"Bollag","year":"2020","journal-title":"Int J Obstet Anesth"},{"issue":"3","key":"R56-20260406","doi-asserted-by":"crossref","first-page":"231-7","DOI":"10.1016\/j.jpain.2008.09.010","article-title":"Individual differences in pain sensitivity: measurement, causation, and consequences","volume":"10","author":"Nielsen","year":"2009","journal-title":"J Pain"},{"issue":"1","key":"R58-20260406","doi-asserted-by":"crossref","first-page":"69-78","DOI":"10.1016\/j.bja.2018.06.011","article-title":"Development and evaluation of an obstetric quality-of-recovery score (ObsQoR-11) after elective Caesarean delivery","volume":"122","author":"Ciechanowicz","year":"2019","journal-title":"Br J Anaesth"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:35:53Z","timestamp":1786451753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-24-00418","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}